Prostate cancer screening is broken in America so I started a company four years ago to fix it. We’re almost there with a highly accurate test for prostate cancer that is urine based. Pee in a cup, know with precision. Details below! i. Over 20 million PSA tests are run each year in the U.S.

ii. More than 70% of positive results are false alarms, leading to over 1 million men undergoing unnecessary biopsies annually.

iii. Even when cancer is found, only 1 in 3 men actually need treatment but many still undergo surgery, radiation, or hormone therapy. These treatments are intense and impact quality of life.

iv. The aggressive cancers, the ones that truly need intervention, often slip by unnoticed. The bottom line is that we’re overtreating the wrong ones and missing the dangerous ones. I started a company with three unbelievably talented scientists four years ago to fix it and we’re making a lot of progress. The company is called @EarlyisGood and if you want to stay informed about high quality cancer screening, please follow us. WRT prostate cancer, we’ve been working with the Mayo Clinic to build a better test. It’s a simple urine test. No blood draws, no rectal exam, and it’s designed to detect only the cancers that actually need treatment. Most urine tests out there still suffer from the same problem as PSA: they can’t accurately tell which cancers are dangerous. That is because they look at one type of signal. That’s why they’re noisy and unreliable. Our test looks at both proteins and RNAs. Proteins tell us what’s happening in our body right now. RNAs show what’s coming next. Together, they give a much clearer signal, so we can accurately tell which cancers are serious and which aren’t. This is possible because of a set of breakthroughs that came from our cofounders post doc research. Using her approach, we are able to detect multiple analytes (DNA, RNA, and proteins) at once, directly from urine. And this is just the start. We also already have a bladder cancer test in final validation. Next up: leverage our multiomic platform to create smarter, more accurate tests for many diseases.